CJASN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published ahead of print on October 22, 2008
Clin J Am Soc Nephrol 4: 119-127, 2009
© 2009 American Society of Nephrology
doi: 10.2215/CJN.03410708

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
CJN.03410708v1
4/1/119    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Toussaint, N. D.
Right arrow Articles by Kerr, P. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Toussaint, N. D.
Right arrow Articles by Kerr, P. G.

Dialysis

Determination and Validation of Aortic Calcification Measurement from Lateral Bone Densitometry in Dialysis Patients

Nigel D. Toussaint*,{dagger}, Kenneth K. Lau{ddagger}, Boyd J. Strauss{dagger},§, Kevan R. Polkinghorne*,{dagger}, and Peter G. Kerr*,{dagger}

* Department of Nephrology, {ddagger} Department of Radiology, and § Clinical Nutrition and Metabolism Unit, Monash Medical Centre, Clayton, Victoria, Australia; and {dagger} Department of Medicine, Monash University, Clayton, Victoria, Australia

Correspondence: Dr. Nigel Toussaint, Department of Nephrology, Monash Medical Centre, 246 Clayton Road, Clayton, Victoria 3168, Australia. Phone: +61 3 9594 3072; Fax: +61 3 9594 6530; E-mail: Nigel.Toussaint{at}med.monash.edu.au

Background and objectives: Vascular calcification (VC) contributes to increased cardiovascular (CV) disease in dialysis patients and is inversely correlated with bone mineral density (BMD). Screening for VC may determine patients at greater CV risk and bone densitometry may have dual role in assessing VC as well as BMD. The aim of this study was to determine measurement of VC using dual-energy x-ray absorptiometry (DXA) with correlation to gold standard computed tomography (CT).

Design, setting, participants, & measurements: Forty hemodialysis patients had abdominal aortic CT and lateral DXA of lumbar spine to determine aortic VC and BMD. Semiquantitative measurement of aortic VC from lateral DXA was determined using previously validated 24- and 8-point scales and correlated with aortic VC with CT. Anteroposterior (AP) and lateral DXA-reported BMD was compared with BMD from L2 through L4 with CT.

Results: Patients, 70% men, 38% diabetic, had median age 58.5 yr. Aortic VC was present in 94% with CT and 68% on lateral DXA. For 24- and 8-point scores, intraclass correlation coefficients for intrarater agreement were 0.93 and 0.88, respectively. DXA-measured VC correlated with CT. Sensitivity and specificity for CT aortic VC ≥ 500 HU was 50 and 86%, respectively, for DXA VC ≥ 6 on a 24-point scale. Lateral DXA-reported BMD significantly correlated with BMD from CT, but AP DXA did not.

Conclusions: Lateral DXA may be useful because images may provide concurrent assessment of aortic calcification as well as more accurate lumbar spine BMD, avoiding some of the limitations of AP DXA.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the American Society of Nephrology.